Avadel Pharmaceuticals plc (NASDAQ:AVDL) is seeking acquisitions. Michael Anderson, Avadel's Chief Executive Officer, commented, "This is an exciting time to join Avadel. The Company is at an inflection point it has a number of ongoing projects, each with potential to add meaningful value, a growing salesforce and a strong balance sheet that provides us the potential to add commercial assets through acquisition. I look forward to playing a role in the Company's continued growth."